These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 12665997)

  • 1. The impact of critical care pharmacists on enhancing patient outcomes.
    Kane SL; Weber RJ; Dasta JF
    Intensive Care Med; 2003 May; 29(5):691-8. PubMed ID: 12665997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist contributions as members of the multidisciplinary ICU team.
    Preslaski CR; Lat I; MacLaren R; Poston J
    Chest; 2013 Nov; 144(5):1687-1695. PubMed ID: 24189862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions.
    MacLaren R; Brett McQueen R; Campbell J
    Pharmacotherapy; 2013 Apr; 33(4):401-10. PubMed ID: 23468188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
    Chan LEJ; Soong JL; Lie SA
    Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provision of pharmaceutical care in the intensive care unit.
    Kilroy RA; Iafrate RP
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):221-5. PubMed ID: 8398030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
    Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdisciplinary patient care in the intensive care unit: focus on the pharmacist.
    Erstad BL; Haas CE; O'Keeffe T; Hokula CA; Parrinello K; Theodorou AA
    Pharmacotherapy; 2011 Feb; 31(2):128-37. PubMed ID: 21275491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
    Kopp BJ; Mrsan M; Erstad BL; Duby JJ
    Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact.
    Bosma BE; van den Bemt PMLA; Melief PHGJ; van Bommel J; Tan SS; Hunfeld NGM
    Neth J Med; 2018 Apr; 76(3):115-124. PubMed ID: 29667584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical care pharmacy workforce: UK deployment and characteristics in 2015.
    Borthwick M; Barton G; Bourne RS; McKenzie C
    Int J Pharm Pract; 2018 Aug; 26(4):325-333. PubMed ID: 29024199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
    Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
    Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK).
    Shulman R; McKenzie CA; Landa J; Bourne RS; Jones A; Borthwick M; Tomlin M; Jani YH; West D; Bates I;
    J Crit Care; 2015 Aug; 30(4):808-13. PubMed ID: 25971871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
    Forni A; Skehan N; Hartman CA; Yogaratnam D; Njoroge M; Schifferdecker C; Lilly CM
    Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Care Pharmacists and Medication Management in an ICU Recovery Center.
    Stollings JL; Bloom SL; Wang L; Ely EW; Jackson JC; Sevin CM
    Ann Pharmacother; 2018 Aug; 52(8):713-723. PubMed ID: 29457491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomics: therapeutic and economic considerations in treating the critically ill patient.
    Crane VS
    DICP; 1990 Nov; 24(11 Suppl):S24-7. PubMed ID: 2125394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.